Ella Foundation, India
efficacious vaccine, diagnostic tools, zoonotic infections.
My current research focused on the development of safe and efficacious vaccine and diagnostic tools to control zoonotic infections.
Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection, Sunagar R et al i in Vaccines
Sunagar R, Kumar S, Namjoshi P, Rosa SJ, Hazlett KRO, Gosselin EJ (2018). Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing, Sunagar R et al, in PLoS One
Differential in vitro cultivation of Francisella tularensis influence the live vaccine protective efficacy by altering the immune response via enhanced virulence, Sunagar R et al, in Frontiers in Immunology
Vaccination evokes gender-dependent protection against tularemia infection in C57BL/6Tac mice, Sunagar R et al, in Vaccine
Ex vivo antigen-pulsed PBMCs generate potent and long-lasting immunity to infection when administered as a vaccine, Sunagar R et al, in Vaccine
Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants, Sunagar R et al, in Front Immunol
Prevalence and clonotype distribution of methicillin-resistant Staphylococcus aureus (MRSA) in India, Sunagar R et al, in Journal of Global Antimicrobial Resistance